Psoriasis and body mass index

Dermatologic Therapy

Volumn 23, Issue 2, 2010, Pages 152-154

  Hercogová, Jana ^a   Ricceri, Frederica ^a   Tripo, Lara ^a   Lotti, Torello ^b   Prignano, Francesca ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Chares University   (Czech Republic)

Author keywords

Body mass index; Metabolic syndrome; Obesity; Psoriasis

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; BODY MASS; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PSORIASIS; SHORT SURVEY;

ADIPOSITY; ANTIBODIES, MONOCLONAL; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN G; INFLAMMATION; MALE; OBESITY; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950150415     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01309.x     Document Type: Short Survey

References (16)

1. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004 : 3 : 121 128.
2. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index and stressful life events as risk factors for psoriasis: result from an Italian case-control study. J Invest Dermatol 2005 : 125 : 61 67.
3. Setty AR, Curhan G, Chointerni HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women. Arch Intern Med 2007 : 167 : 1670 1675.
4. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001 : 60 : 329 339.
5. Hammiga EA, van der Lely AJ, Neumann HAM, Thio HB. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006 : 67 : 768 773.
6. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediator of cutaneous inflammation. Br J Dermatol 2008 : 159 : 342 350.
7. Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990 : 85 : 962 963.
8. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 : 32 : 982 986.
9. Pearce DJ, Morrison AE, Higgins KB, et al. The comorbidity state of psoriasis patients in a university dermatology practice. J Derm Treat 2005 : 6 : 319 323.
10. Cohen AD Sherf M, Vidavsky L. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008 : 216 : 152 155.
11. Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic state. Report of the National Heart, Lung and Blood Institut/American Heart Association conference of scientific issues related to definition. Circulation 2004 : 109 : 433 438.
12. Matsumoto T, Suzuki N, Watanabe H, et al. Nonalcoholic steatohepatitis associated with psoriasis vulgaris. J Gastroenterol 2004 : 39 : 1102 1105.
13. Buslau M, Benotmane K. Cardiovascular complications of psoriasis: does obstructive sleep apnoea play a role? Acta Derm Venereol 1999 : 79 : 234.
14. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002 : 2 : 862 871.
15. Gisondi P, Cotena C, Tessari G, Girolomoni G. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. Eur Acad Dermatol Venereol 2008 : 22 : 341 344.
16. Prignano F, Ricceri F, Buggiani G, et al. Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biologic therapies. Curr Med Res 2009 : 25 : 2311 2316.